These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 18813780)
21. Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts. Lindström MS; Wiman KG Oncogene; 2003 Aug; 22(32):4993-5005. PubMed ID: 12902982 [TBL] [Abstract][Full Text] [Related]
22. Zoledronic acid activates the DNA S-phase checkpoint and induces osteosarcoma cell death characterized by apoptosis-inducing factor and endonuclease-G translocation independently of p53 and retinoblastoma status. Ory B; Blanchard F; Battaglia S; Gouin F; Rédini F; Heymann D Mol Pharmacol; 2007 Jan; 71(1):333-43. PubMed ID: 17050806 [TBL] [Abstract][Full Text] [Related]
23. Anticancer activity of isoobtusilactone A from Cinnamomum kotoense: involvement of apoptosis, cell-cycle dysregulation, mitochondria regulation, and reactive oxygen species. Chen CY; Chen CH; Lo YC; Wu BN; Wang HM; Lo WL; Yen CM; Lin RJ J Nat Prod; 2008 Jun; 71(6):933-40. PubMed ID: 18489163 [TBL] [Abstract][Full Text] [Related]
24. E2F-1 overexpression in U2OS cells increases cyclin B1 levels and cdc2 kinase activity and sensitizes cells to antimitotic agents. Russo AJ; Magro PG; Hu Z; Li WW; Peters R; Mandola J; Banerjee D; Bertino JR Cancer Res; 2006 Jul; 66(14):7253-60. PubMed ID: 16849574 [TBL] [Abstract][Full Text] [Related]
25. Induction of G2/M arrest and apoptosis by sesquiterpene lactones in human melanoma cell lines. Rozenblat S; Grossman S; Bergman M; Gottlieb H; Cohen Y; Dovrat S Biochem Pharmacol; 2008 Jan; 75(2):369-82. PubMed ID: 17919456 [TBL] [Abstract][Full Text] [Related]
26. Paclitaxel induces apoptosis via caspase-3 activation in human osteogenic sarcoma cells (U-2 OS). Lu KH; Lue KH; Chou MC; Chung JG J Orthop Res; 2005 Sep; 23(5):988-94. PubMed ID: 16140185 [TBL] [Abstract][Full Text] [Related]
27. Induction of apoptosis by vinblastine via c-Jun autoamplification and p53-independent down-regulation of p21WAF1/CIP1. Kolomeichuk SN; Bene A; Upreti M; Dennis RA; Lyle CS; Rajasekaran M; Chambers TC Mol Pharmacol; 2008 Jan; 73(1):128-36. PubMed ID: 18094076 [TBL] [Abstract][Full Text] [Related]
28. Asparanin A induces G(2)/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells. Liu W; Huang XF; Qi Q; Dai QS; Yang L; Nie FF; Lu N; Gong DD; Kong LY; Guo QL Biochem Biophys Res Commun; 2009 Apr; 381(4):700-5. PubMed ID: 19254688 [TBL] [Abstract][Full Text] [Related]
29. 2-Methoxyestradiol and paclitaxel have similar effects on the cell cycle and induction of apoptosis in prostate cancer cells. Perez-Stable C Cancer Lett; 2006 Jan; 231(1):49-64. PubMed ID: 16356831 [TBL] [Abstract][Full Text] [Related]
31. Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels. Baiz D; Pozzato G; Dapas B; Farra R; Scaggiante B; Grassi M; Uxa L; Giansante C; Zennaro C; Guarnieri G; Grassi G Biochimie; 2009 Mar; 91(3):373-82. PubMed ID: 19041685 [TBL] [Abstract][Full Text] [Related]
32. Cycloheximide protects HepG2 cells from serum withdrawal-induced apoptosis by decreasing p53 and phosphorylated p53 levels. Bai J; Cederbaum AI J Pharmacol Exp Ther; 2006 Dec; 319(3):1435-43. PubMed ID: 16971506 [TBL] [Abstract][Full Text] [Related]
33. Mechanism of G1-like arrest by low concentrations of paclitaxel: next cell cycle p53-dependent arrest with sub G1 DNA content mediated by prolonged mitosis. Demidenko ZN; Kalurupalle S; Hanko C; Lim CU; Broude E; Blagosklonny MV Oncogene; 2008 Jul; 27(32):4402-10. PubMed ID: 18469851 [TBL] [Abstract][Full Text] [Related]
34. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F. Hershko T; Chaussepied M; Oren M; Ginsberg D Cell Death Differ; 2005 Apr; 12(4):377-83. PubMed ID: 15706352 [TBL] [Abstract][Full Text] [Related]
35. Paclitaxel (Taxol) upregulates expression of functional interleukin-6 in human ovarian cancer cells through multiple signaling pathways. Wang TH; Chan YH; Chen CW; Kung WH; Lee YS; Wang ST; Chang TC; Wang HS Oncogene; 2006 Aug; 25(35):4857-66. PubMed ID: 16547493 [TBL] [Abstract][Full Text] [Related]
36. rBTI induces apoptosis in human solid tumor cell lines by loss in mitochondrial transmembrane potential and caspase activation. Li YY; Zhang Z; Wang ZH; Wang HW; Zhang L; Zhu L Toxicol Lett; 2009 Sep; 189(2):166-75. PubMed ID: 19481592 [TBL] [Abstract][Full Text] [Related]
37. Silvestrol regulates G2/M checkpoint genes independent of p53 activity. Mi Q; Kim S; Hwang BY; Su BN; Chai H; Arbieva ZH; Kinghorn AD; Swanson SM Anticancer Res; 2006; 26(5A):3349-56. PubMed ID: 17094452 [TBL] [Abstract][Full Text] [Related]
38. Purvalanol A enhances cell killing by inhibiting up-regulation of CDC2 kinase activity in tumor cells irradiated with high doses of X rays. Iizuka D; Inanami O; Kashiwakura I; Kuwabara M Radiat Res; 2007 May; 167(5):563-71. PubMed ID: 17474786 [TBL] [Abstract][Full Text] [Related]
39. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression. Farrell GC; Larter CZ; Hou JY; Zhang RH; Yeh MM; Williams J; dela Pena A; Francisco R; Osvath SR; Brooling J; Teoh N; Sedger LM J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377 [TBL] [Abstract][Full Text] [Related]
40. Effect of c-Abl tyrosine kinase on the cellular response to paclitaxel-induced microtubule damage. Nehmé A; Lee BL; Baskaran R; Zhang Q; Lin X; Christen RD Br J Cancer; 2000 Nov; 83(10):1360-6. PubMed ID: 11044362 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]